Special Issue "Safety and Efficacy of COVID-19 Vaccine"
Deadline for manuscript submissions: closed (30 June 2023) | Viewed by 11375
Interests: vaccine immunology and evaluation
Vaccination is the most effective way to prevent the spread of SARS-CoV-2 and COVID-19 complications. Evaluation of vaccine safety and efficacy is critical in the pre-clinical stage, and in clinical trials. The molecular immune mechanisms of different vaccines need to be interpreted broadly, including humoral antibody, T-cell and innate immune response in animal models and target populations.
The aim of this Special Issue is to highlight the vaccine research focused on safety and efficacy related to host immunity and COVID-19.
We look forward to receiving your contributions.
Prof. Dr. Longding Liu
Dr. Ming Sun
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Vaccines is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.